Illumina Announces Mitsubishi Chemical Safety Institute as Japan's First Certified Genetic Analysis Service Provider
Illumina, Inc., (NASDAQ:ILMN) today announced that Mitsubishi Chemical Safety Institute, a provider of various analyses, examinations, and services for pharmaceutical companies, public institutions, and chemical companies, is the first organization in Japan to become an Illumina CSPro(R) (certified service provider). Illumina CSPro is a collaborative service provider partnership dedicated to ensuring the delivery of the highest-quality data available for genetic analysis applications. Mitsubishi Chemical Safety Institute offers its customers whole-genome and targeted-genotyping services using Illumina’s Infinium(R) and GoldenGate(R) Assays. Both assays leverage Illumina’s proprietary BeadArray(R) technology to provide customers the ability to perform large-scale interrogation of the human genome, which enables them to cost-effectively fast forward their research and identify genetic variants linked to disease.
Source: Illumina
